For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Pacira Pharmaceuticals, Inc.

USPTO Granted Patents = 57

EPO Patents = 11

Trademarks = 10

Forward Citations = 705

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Kathleen D A Los (26 out of 26 patents)

John J Grigsby, Jr (25 out of 25 patents)

Jeffrey S Hall (23 out of 24 patents)

4. Soroush M Ardekani (20 out of 20 patents)

5. Louie Daniel Garcia (19 out of 19 patents)

6. David J Turnbull (16 out of 16 patents)

7. Stephanie M Kurz (11 out of 11 patents)

8. Ernest George Schutt (10 out of 66 patents)

9. Paige N Davis (9 out of 9 patents)

10. Eran Levy (9 out of 9 patents)

11. Liangjin Zhu (8 out of 8 patents)

12. Ronald Warren McGuire (8 out of 8 patents)

13. Peter Andrew Walters (8 out of 8 patents)

14. Roy Winston (8 out of 8 patents)

15. William Joseph Lambert (7 out of 7 patents)

Core Competencies:

Bupivacaine

Multivesicular Liposomes

Sustained Release Formulations

Liposomal Anesthetic Compositions

Dexamethasone

Pain Management

Pediatric Pain Treatment

Post-Operative Pain

Zinc Meloxicam Complex

Synthetic Membrane Vesicles

Non-Steroidal Anti-Inflammatory Drugs

Methotrexate

57 patents: Sort by Forward Citations

1. 12433878 - Uses of bupivacaine multivesicular liposomes as stellate ganglion block (2025-10-07),

2. 12370142 - Manufacturing of bupivacaine multivesicular liposomes (2025-07-29),

3. 12318483 - Manufacturing of bupivacaine multivesicular liposomes (2025-06-03),

4. 12296047 - Manufacturing of bupivacaine multivesicular liposomes (2025-05-13),

5. 12285435 - Multivesicular liposome formulations of dexamethasone (2025-04-29),

6. 12285419 - Bupivacaine multivesicular liposome formulations and uses thereof (2025-04-29),

7. 12280149 - Manufacturing of bupivacaine multivesicular liposomes (2025-04-21),

8. 12251472 - Manufacturing of bupivacaine multivesicular liposomes (2025-03-18),

9. 12251468 - Manufacturing of bupivacaine multivesicular liposomes (2025-03-18),

10. 12246092 - Manufacturing of bupivacaine multivesicular liposomes (2025-03-11),

11. 12226610 - Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions (2025-02-18),

12. 12178909 - Manufacturing of bupivacaine multivesicular liposomes (2024-12-31),

13. 12156940 - Manufacturing of bupivacaine multivesicular liposomes (2024-12-03),

14. 12151024 - Manufacturing of bupivacaine multivesicular liposomes (2024-11-26),

15. 12144890 - Manufacturing of bupivacaine multivesicular liposomes (2024-11-19),

Pacira Pharmaceuticals, Inc. is a leading specialty pharmaceutical company that develops and commercializes innovative products for acute care and ambulatory surgery patients. They are focused on providing non-opioid treatment options to manage pain and maximize patient outcomes. With a mission to improve patient care by advancing the field of analgesia, Pacira is committed to delivering innovative solutions that meet the needs of healthcare professionals and their patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

57 Patents

#107 in San Diego, CA

#1,424 in California

#6,037 in US

#12,152 in the World

San Diego, CA, United States of America

Pacira Pharmaceuticals, Inc.

Forward Citations = 705

43 inventors:

Kathleen D A Los (26 out of 26 patents)

John J Grigsby, Jr (25 out of 25 patents)

Jeffrey S Hall (23 out of 24 patents)

4. Soroush M Ardekani (20 out of 20 patents)

5. Louie Daniel Garcia (19 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…